A single gene (mas) encodes the multifunctional enzyme that catalyzes the synthesis of very long chain multiple methyl branched fatty acids called mycocerosic acids that are present only in slow-growing pathogenic mycobacteria and are thought to be important for pathogenesis. To achieve a targeted disruption ofmas, an internal 2-kb segment of this gene was replaced with approximately the same size hygromycin-resistance gene (hyg), such that hyg was flanked by 4.7-and 1.4-kb segments of mas. Transformation of Mycobacterium bovis BCG with this construct in a plasmid that cannot replicate in mycobacteria yielded hygromycinresistant transformants. Screening of 38 such transformants by PCR revealed several transformants representing homologous recombination with single crossover and one with double crossover. With primers representing the hyg termini and those representing the mycobacterial genome segments outside that used to make the transformation construct, the double-crossover mutant yielded PCR products expected from either side ofhyg. Gene replacement was further confirmed by the absence of the vector and the 2-kb segment ofmas replaced by hyg from the genome of the mutant. Thin-layer and radio-gas chromatographic analyses of the lipids derived from [1-14C]propionate showed that the mutant was incapable of synthesizing mycocerosic acids and mycosides. Thus, homologous recombination with double crossover was achieved in a slow-growing mycobacterium with an intron-containing RecA. The resulting mas-disrupted mutant should allow testing of the postulated roles of mycosides in pathogenesis.
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Tuberculosis, caused by Mycobacterium tuberculosis, afflicts over 30 million people throughout the world, resulting in 3 million deaths per year (1) . The increasing incidence of tuberculosis in patients with AIDS and the emergence of multidrug-resistant strains have further emphasized the need for more efficient control of this infectious disease (2) (3) (4) . The unique cell-wall components of mycobacteria are thought to play a major role in their ability to resist the host defense mechanisms and multiply in the host (5) (6) (7) (8) . Inhibition of synthesis of one of the unique wall lipids (mycolic acids) has been a major part of a long-standing strategy for antimycobacterial therapy (9, 10) . With the development of resistance against such drugs, other targets need to be identified (11) . Biosynthesis of phenolic glycolipids (mycosides) that are found uniquely in pathogenic mycobacteria (12) (13) (14) could offer such targets. The major phenolic glycolipids are composed of glycosylated phenol-phthiocerol diesters of multiple methyl branched very long chain fatty acids called mycocerosic acids (15) (16) (17) . A multifunctional enzyme that catalyzes the synthesis of such fatty acids has been purified (18) , and the gene that encodes this mycocerosic acid synthase has been cloned (19) . Gene replacement by homologous recombination provides a powerful means to create a null mutation in a specific gene and to study gene function(s). Although gene replacement was demonstrated in the fast-growing nonpathogenic mycobacterial species, Mycobacterium smegmatis (20, 21) , such replacement has not been achieved in slow-growing mycobacteria such as M tuberculosis and Mycobacterium bovis BCG. Attempts with these species have resulted either in apparent random integration of the transformed DNA by nonhomologous recombination (22) *To whom reprint requests should be addressed.
4787
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. mycocerosic acid synthase (19) , as probes. An 8.1-kb BstBI fragment, containing the mas gene and its flanking regions, was isolated from the cosmid, made blunt-ended by filling-in reaction with Klenow polymerase, and cloned into the unique SmaI site of pUC19 (Life Technologies) to produce pATP9. A 2-kb internal fragment of the mas-coding region was deleted by digestion of pATP9 with Stul and replaced with a 1.8-kb hyg gene from Streptomyces hygroscopicus (25) , which has been demonstrated to be a better selectable marker than kanamycin for mycobacterial species (26) . Plasmid pIJ963 (a gift from David Hopwood, John Innes Centre, Norwich, U.K.) was used as a source of the hyg cassette that was excised from the plasmid as a 1.8-kb BglII-BamHI fragment, blunt-ended with Klenow enzyme, and ligated into the Stul sites of the pUC19-mas gene backbone of pATP9 to generate the disruption construct pATP10. Following subcloning at each step, the structure of the construct was examined by restriction enzyme analysis, Southern hybridization, and sequencing of the ligation junctions. All DNA-manipulating enzymes used were purchased either from Life Technologies, New England Biolabs, or Amersham.
Electroporation of M. bovis BCG. BCG cultures were grown in M-ADC-TW broth in roller bottles to an OD600 of 0.8-1.0 (7-9 days), and competent cells were made as described (27) , except that the cells were exposed to 1.5% glycine for 24 h before harvest. A 0.1 ml aliquot of BCG cell suspension from the frozen stock was mixed with 2-3 jig of plasmid DNA, the mixture was incubated on ice for 10 min and subjected to electroporation in a 0.2-cm cuvette with a BTX Electro Cell Manipulator (BTX, San Diego) at a setting of 2.5 kV, capacitance to 25 t,F, and pulse controller to 720 fl. The cells were then placed on ice for 10 min, resuspended in 0.5 ml M-ADC-TW broth, transferred to a 15-ml conical polypropylene tube, and incubated overnight with shaking at 37°C. The transformed cultures were spread on three 7H11 agar plates containing hygromycin B (50 ,ug/ml) and cycloheximide (Sigma; 10 j,g/ml) to prevent fungal contamination. Seeded plates were sealed with parafilm to prevent drying and incubated at 37°C for 3-4 weeks.
Genomic DNA Isolation and Southern Blot Analysis. Genomic DNA from BCG cultures was extracted as described (27) by disrupting the cells with 425-to 600-,um glass beads (Sigma) in a Mini-Beadbeater Cell Disruptor (Biospec Products, Bartlesville, OK). DNA samples were digested with restriction enzymes and fragments were separated on 0.8% agarose gels and transferred to nylon membrane (Nytran Plus; Schleicher & Schuell) followed by baking at 80°C for 2 h. Prehybridization, hybridization, and washing of the blot under high stringency conditions were carried out according to standard procedures (28 (30, 31) , was scraped off and lipids were recovered by elution with ethyl ether. These ester fractions were refluxed with 5% KOH in 2-methoxyethanol containing 12% water for 3 h (32). The mixture was diluted with water acidified with HCl and extracted with chloroform; the solvent was then evaporated under reduced pressure. The residue was refluxed with 14% BF3 in methanol for 1 h. The products, recovered by extraction with chloroform after dilution with water, were subjected to thin-layer chromatography on silica gel G plates with hexane/ethyl ether/formic acid (40:10:1, wt/vol) as the solvent. After scanning the plates for '4C, the labeled components were recovered and the methyl ester fractions that contained most of the 14C were subjected to radio gas-liquid chromatography on 3.2 mm x 2 m 3% OV-101 column with Varian model 3300 gas chromatograph attached to a Lablogic GC-RAM radioactivity monitor (INUS Systems, Tampa, FL) with a column temperature of 180-300°C, programmed at 20°C per min followed by a 6-min isothermal period with a carrier gas (He) flow of 30 ml/min. The labeled mycocerosic acids were identified as before (18) . 14C in aliquots were assayed with a Beckman LS3801 liquid scintillation spectrometer with Scintiverse BD as the counting fluid at 95% efficiency for 14C.
RESULTS
Construct for mas Gene Disruption. The mas gene from M. bovis BCG, composed of a 6.4-kb coding region, a 1.2-kb 5'-flanking region, and a 0.5-kb 3'-flanking region, was used for making the construct for gene disruption. An internal 2-kb segment from the open reading frame was replaced with a 1.8-kb hyg gene of approximately the same size as the selectable marker. This pUC-based construct (Fig. la) contains, in addition to the hyg gene that is known to be functional in mycobacterial species (26) , an E. coli origin of replication but not a mycobacterial origin of replication. Therefore, hygromycin-resistant transformants can result only from integration of the plasmid into the mycobacterial genome. (Fig. 1 c and d) . This set of primers would generate a 4.8-kb PCR product in the case of homologous recombination. PCR was also done with another set of primers representing the 3' terminus of the hyg gene (H2) and a unique sequence from the 3'-flanking region of mas in the M. bovis BCG genome adjacent to the expected integration site but absent from the vector construct (B2) (Fig. ld) . This set of primers would generate a 1.4-kb product if the transforming DNA integrates by homologous recombination into the mycobacterial genome. Integration by a double crossover would yield both 1.4-and 4.8-kb products with the two sets of primers. Analysis of 38 hygromycin-resistant transformants by such a PCR analysis showed three mutants with single crossover events, two yielding a 1.4-kb product and one (BM-19) yielding a 4.8-kb product. One mutant, designated BM-18, yielded both 1.4-and 4.8-kb products (Fig. 2) , as expected from homologous recombination by double crossover causing replacement of the native mas gene by a disrupted copy of the gene (Fig. ld) . Because the transformant BM-19 ( Fig. lc) was generated by the single-crossover event at the 5' side of the mas locus, only the larger PCR product (4.8 kb) was obtained ( Fig. 2A) .
The gene disruption by double crossover was further analyzed by Southern hybridization. When the 2-kb internal segment of the mas gene that was replaced by the hyg gene was used as the probe, only the mas gene-disrupted mutant (BM-18) failed to show hybridization; the wild-type and the hygromycin-resistant transformants, including the single crossover integrant (BM-19), showed the expected hybridization bands (Fig. 3A) . The mas gene-disrupted mutant and all of the other hygromycinresistant transformants hybridized with the hyg gene probe (Fig. 3B) . As expected from double crossover event, DNA from the mas gene-disrupted mutant showed no hybridization with the vector probe, whereas all of the other transformants hybridized with the same probe (transformants generated with the excised insert did not contain vector) (Fig. 3C) . To confirm that the PCR products generated from either side of the hyg gene (3-4 ,ug) was digested with BamHI, transferred to nylon membrane, and probed with 2-kb internal mas fragment (P in Fig. 1 were used as probes for Southern hybridization of the PCR products. As expected, only the 4.8-kb product hybridized with the acyl transferase probe and the 1.4-kb product hybridized with the acyl carrier protein probe (Fig. 4) . The mutant was stable after repeated (eight times) subculturing with or without hygromycin over a period of 4 months.
Mycocerosic Acid Biosynthesis by M. bovis BCG and its mas Disrupted Mutant. To test whether mas gene disruption eliminated the ability of the organism to synthesize mycocerosic acid, [1-14C] propionate incorporation into lipids by the wild-type BCG and its mas-disrupted mutant was examined.
Overnight incubation with [1-14C] propionate under sterile conditions resulted in the incorporation of 13.4% and 5.6% of the administered label into total lipids by the wild type and mutant, respectively. Thin-layer chromatographic analysis showed two major labeled components corresponding to phthiocerol ester fraction and phenol-phthiocerol ester fraction in the wild type, whereas no labeling was detected in the phenolphthiocerol ester (mycoside) region in the mas-disrupted mutant (Fig. SA) . Charring of the chromatograms clearly showed two major components corresponding to phthiocerol ester waxes and mycosides in the wild-type but in the masdisrupted mutant only phthiocerol esters could be found with no bands corresponding to mycosides (Fig. SB) . Nearly 40% and >50% of the 14C contained in the total lipids was found in the phthiocerol and phenol-phthiocerol ester fractions, respectively, in the wild type, whereas most (98%) of the label in the lipids in the mutant was contained in phthiocerol esters. When the acyl and alcohol portions of the ester fractions were separated by base hydrolysis, most of the label ("90%) was found to be in the acyl portion both in the wild-type and the mas-disrupted mutant. In the wild type almost 10% of the label in the phenol-phthiocerol ester fraction was contained in a polar material tentatively identified as phenol-phthiocerol (data not shown). Radio-gas chromatographic analysis of the methyl esters of the fatty acids showed that the major part of the label was contained in C29 and C32 mycocerosic acids of the phenol-phthiocerol esters in the wild type (Fig. 6 ), whereas this ester fraction was absent in the mutant. The phthiocerol ester fraction of the wild type also contained significant amounts of C29 and C32 mycocerosic acids, whereas the corresponding fraction from the mutant contained only shorter fatty acids with no mycocerosic acids (Fig. 6) . Obviously, mas genedisrupted mutant could not synthesize mycocerosic acids. DISCUSSION Mycocerosic acid-containing lipids, being found only in pathogenic mycobacterial cell walls, have been suggested to be important for pathogenicity (12) (13) (14) . However, direct evidence for such a hypothesis is lacking. Replacement of gene(s) involved in the biosynthesis of such lipids would be one approach to make a direct test. Earlier efforts to achieve targeted gene disruption in slow-growing mycobacteria were unsuccessful as only nonhomologous recombinations were observed (22) . Attempts to achieve homologous recombination by increasing the efficiency of transformation yielded mutants with single crossover in M. bovis BCG, but without gene replacement (23) . Efforts to increase probability of (35, 36) . In the murine embryonic stem cells, homologous recombination increased most dramatically when the length of the flanking region was increased up to 4.2 kb with some further increase when the length reached 6 kb and no further increases with longer inserts (36) . The (19) , replacement of this gene should be expected to make the mutant incapable of synthesizing mycocerosic acids. The use of [1-14C] propionate to specifically label mycocerosic acids clearly showed that the mutant was incapable of synthesizing mycocerosic acids. The wild-type M. bovis BCG incorporated significant amounts of the labeled propionate specifically into phthiocerol ester wax and glycosyl phenol-phthiocerol esters (mycoside). In the mas-disrupted mutant, labeled mycocerosic acids were absent in the acyl portion of both ester groups. Since [1-14C] propionate is also incorporated into phenol-phthiocerol, albeit much less than that incorporated into the mycocerosic acids, the observation that no labeled mycosides were found in the mas-disrupted mutant suggests that in the absence of mycocerosic acids acylated phenol-phthiocerols are not produced, presumably because the cells do not substitute other fatty acids for mycocerosic acids in the acylation steps. No mycoside was seen in the charred thin-layer chromatograms of the total lipids from the mutant, whereas the mycoside band in the wild type was obvious. If other fatty acids could be substituted, mycosides should be detectable in the mutant even 12:00 min A I -i -,i if they were not labeled. Thus, in the cell wall of the mutant the normal mycosides are not substituted by other mycosides with a fatty acid composition different from that of the wild type. This finding is consistent with our previous conclusion that the synthase probably transfers mycocerosyl groups directly to phenol-phthiocerol (18) . The absence of a significant structural component of the cell wall, that has been postulated to be involved in the ability of the organism to multiply in the host, might have important biological consequences in the mycobacterial interactions with the host. The availability of the mas gene-disrupted mutant should allow exploration of these biological consequences.
Note Added in Proof. Two other gene replacements in Mycobacteria have recently been reported (37, 38) .
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